NCT01786031
Completed
N/A
Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Metastatic Castration Resistant Prostate Cancer Patients
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Enrollment
- 55
- Locations
- 1
- Primary Endpoint
- Biomarker
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
Toward personalised treatment in early metastatic prostate cancer based on the assessment of biomarkers in cancer tissue samples and circulating tumour cells.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Prostate Cancer patients
- •Castration Resistant
- •Prostatic tissue available
- •Metastasis which may be biopsied
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Biomarker
Time Frame: assessed at the end of recruitment, up to 2 years
success to evaluate at least one molecular analysis in tumor tissues (prostate and/or metastatic site) AND in CTC
Study Sites (1)
Loading locations...
Similar Trials
Unknown
N/A
Biomarkers in Prostate Cancer Treated With SRP Following Failure of FATProstatic NeoplasmsNCT03533998Institut Mutualiste Montsouris30
Completed
N/A
Evaluation of Prostate Cancer MarginsProstate CancerNCT05317143Intuitive Surgical100
Completed
N/A
Tailored treatment of prostate cancer by biomarkers: PROCABIOprostate cancerProstate carcinoma1003858810036958NL-OMON33361Erasmus MC, Universitair Medisch Centrum Rotterdam50
Active, Not Recruiting
Early Phase 1
Imaging and Genomic Biomarkers to Predict Response in Prostate CancerProstate CancerNCT05477823University of Wisconsin, Madison30
Recruiting
Phase 2
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialCastration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8NCT06632977Alliance for Clinical Trials in Oncology474